(Bloomberg) -- Canada’s public health agency licensed Johnson & Johnson’s coronavirus vaccine, making it the fourth shot authorized in a country struggling to keep up with its Group of Seven peers on inoculations.
The approval, first reported by Canadian Broadcasting Corp.